Jed Gorden, MD, Director, Interventional Pulmonology, Swedish Cancer Institute, Seattle, WA, discusses interventional pulmonology and novel techniques for the diagnosis of lung diseases. References and Resources Gasparini S.…
Ralph W. Aye, MD, Program Leader, Thoracic Oncology Program, Swedish Cancer Institute, Seattle, WA, discusses the possibility of the use of sputum analysis for lung cancer screening. References…
Ralph W. Aye, MD, Program Leader, Thoracic Oncology Program, Swedish Cancer Institute, Seattle, WA, shares his thoughts on the cost of lung cancer screening. Sponsored by The Doctor’s…
For patients on continuous medication for pain relief in late-stage illness, the FDA has approved methylnaltrexone bromide (Relistor) injection for treatment of opioid-induced constipation. References and Resources FDA…
According to results of a multicenter randomized clinical trial, patients with advanced NSCLC derived no benefit from the addition of sorafenib (Nexavar) to chemotherapy. References and Resources Scagliotti…
Vivek K. Mehta, MD, Radiation Oncologist, Director, Center for Advanced Targeted Radiotherapies, Department of Radiation Oncology, Swedish Cancer Institute, Seattle, WA, discusses advances in partial breast radiation. References…
At the 2008 Atlantic Regional Osteopathic Convention, Joseph Minniti, Founder and Director of The Cancer Foundation for Personal Appearance Inc., gives feedback on how The Doctor’s Channel has…
Greg Foltz, MD, Director, Center for Advanced Brain Tumor Treatment, Swedish Neuroscience Institute, Seattle, Washington, discusses the Center for Advanced Brain Tumor Treatment. For more information visit: Center…
Greg Foltz, MD, Director, Center for Advanced Brain Tumor Treatment, Swedish Neuroscience Institute, Seattle, WA, discusses current treatments for brain cancer. References and Resources Schönekaes K, Mücke R,…
A feasibility study presented at the American Association for Cancer Research meeting showed that intraductal chemotherapy may have potential as a treatment for ductal carcinoma in situ and…
